NO20061468L - Anvendelse av tigecyklin, alene eller i kombinasjonmed rifampin for behandling av osteomyelitt og/eller septisk artritt - Google Patents

Anvendelse av tigecyklin, alene eller i kombinasjonmed rifampin for behandling av osteomyelitt og/eller septisk artritt

Info

Publication number: NO20061468L
Authority: NO; Norway
Prior art keywords: joint; combination; infection; rifampin; treatment
Prior art date: 2003-09-05

Application number

NO20061468A

Other languages

English (en)

Norwegian (no)

Inventor

Jon T Mader

Jason Calhoun

Raymond Thomas Testa

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-09-05

Filing date

2006-03-31

Publication date

2006-05-31

2006-03-31 Application filed by Wyeth Corp filed Critical Wyeth Corp

2006-05-31 Publication of NO20061468L publication Critical patent/NO20061468L/no

Links

FPZLLRFZJZRHSY-HJYUBDRYSA-N tigecycline Chemical compound C([C@H]1C2)C3=C(N(C)C)C=C(NC(=O)CNC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O FPZLLRFZJZRHSY-HJYUBDRYSA-N 0.000 title abstract 3
229960004089 tigecycline Drugs 0.000 title abstract 3
206010053555 Arthritis bacterial Diseases 0.000 title abstract 2
208000004575 Infectious Arthritis Diseases 0.000 title abstract 2
206010031252 Osteomyelitis Diseases 0.000 title abstract 2
JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 title abstract 2
229960001225 rifampicin Drugs 0.000 title abstract 2
201000001223 septic arthritis Diseases 0.000 title abstract 2
208000015181 infectious disease Diseases 0.000 abstract 6
206010060968 Arthritis infective Diseases 0.000 abstract 3
210000000988 bone and bone Anatomy 0.000 abstract 3
210000001185 bone marrow Anatomy 0.000 abstract 3
210000001519 tissue Anatomy 0.000 abstract 3
230000003115 biocidal effect Effects 0.000 abstract 2
229930189077 Rifamycin Natural products 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
229960003292 rifamycin Drugs 0.000 abstract 1
HJYYPODYNSCCOU-ODRIEIDWSA-N rifamycin SV Chemical compound OC1=C(C(O)=C2C)C3=C(O)C=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O HJYYPODYNSCCOU-ODRIEIDWSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Physical Education & Sports Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Farming Of Fish And Shellfish (AREA)
Dental Preparations (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Glass Compositions (AREA)

NO20061468A 2003-09-05 2006-03-31 Anvendelse av tigecyklin, alene eller i kombinasjonmed rifampin for behandling av osteomyelitt og/eller septisk artritt NO20061468L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US50047403P	2003-09-05	2003-09-05
US10/933,455 US20050148553A1 (en)	2003-09-05	2004-09-03	Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis
PCT/US2004/028980 WO2005023263A1 (en)	2003-09-05	2004-09-07	Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis

Publications (1)

Publication Number	Publication Date
NO20061468L true NO20061468L (no)	2006-05-31

Family

ID=36283191

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20061468A NO20061468L (no)	2003-09-05	2006-03-31	Anvendelse av tigecyklin, alene eller i kombinasjonmed rifampin for behandling av osteomyelitt og/eller septisk artritt

Country Status (23)

Country	Link
US (1)	US20050148553A1 (pl)
EP (1)	EP1663233B1 (pl)
JP (1)	JP2007504249A (pl)
KR (1)	KR20060072135A (pl)
CN (1)	CN1889957A (pl)
AT (1)	ATE401888T1 (pl)
AU (1)	AU2004270231A1 (pl)
BR (1)	BRPI0413770A (pl)
CA (1)	CA2537281A1 (pl)
CO (1)	CO5690590A2 (pl)
DE (1)	DE602004015307D1 (pl)
DK (1)	DK1663233T3 (pl)
EC (1)	ECSP066482A (pl)
ES (1)	ES2311860T3 (pl)
IL (1)	IL173878A0 (pl)
MX (1)	MXPA06002414A (pl)
NO (1)	NO20061468L (pl)
PL (1)	PL1663233T3 (pl)
PT (1)	PT1663233E (pl)
RU (1)	RU2329047C2 (pl)
SI (1)	SI1663233T1 (pl)
UA (1)	UA83250C2 (pl)
WO (1)	WO2005023263A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PA8652001A1 (es) *	2004-11-05	2006-10-13	Wyeth Corp	Metabolitos glucuronidos de tigeciclina y epimeros de los mismos
ES2434944T5 (es)	2005-03-14	2022-10-20	Wyeth Llc	Composiciones de tigeciclina y procedimientos de preparación
CN101340895A (zh) *	2005-12-22	2009-01-07	惠氏公司	包含替加环素的口服制剂
BRPI0620430A2 (pt) *	2005-12-22	2011-11-08	Wyeth Corp	métodos para tratar infecções do trato gastrointestinal com tigeciclina
MD4009C2 (ro) *	2008-07-15	2010-08-31	Институт Химии Академии Наук Молдовы	Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos
WO2011009012A1 (en) *	2009-07-15	2011-01-20	Columbia University	METHODS OF SUPPRESSING APPETITE BY THE ADMINISTRATION OF ANTAGONISTS OF THE SEROTONIN HTR1a or HTR2b RECEPTORS OR INHIBITORS OF TPH2
EP2544692A4 (en) *	2010-03-10	2013-08-07	Univ Health Network	USE OF TIGECYCLIN FOR THE TREATMENT OF CANCER
RU2454252C1 (ru) *	2010-12-29	2012-06-27	Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО НижГМА Росздрава)	Способ профилактики гнойно-септических осложнений (гсо) при операциях на толстой кишке
KR101626544B1 (ko) *	2013-08-07	2016-06-02	서울대학교산학협력단	프롤릴 히드록실라아제 저해제 또는 히스톤 탈아세틸라아제 저해제, 및 항생제를 포함하는 골질환의 예방 또는 치료용 약학적 조성물
US20210369675A1 (en) *	2016-08-20	2021-12-02	John Malcolm Hall Gregg	Antimicrobial drug methods of use & therapeutic compositions
CN112843071A (zh) *	2020-09-08	2021-05-28	天津国际生物医药联合研究院	土霉素或者替加环素在抗分枝杆菌感染中的潜在应用
KR102820113B1 (ko) *	2022-06-15	2025-06-12	순천향대학교 산학협력단	골수염 동물 모델 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5494903A (en) *	1991-10-04	1996-02-27	American Cyanamid Company	7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
RU2152214C1 (ru) *	1997-06-16	2000-07-10	Нижегородский государственный научно-исследовательский институт травматологии и ортопедии	Способ лечения острого остеомиелита
US6582719B2 (en) *	2001-02-02	2003-06-24	The Trustees Of Columbia University In The City Of New York	Combinations of antiseptic and antibiotic agents that inhibit the development of resistant microorganisms
GB0114672D0 (en) *	2001-06-15	2001-08-08	Orthogenics As	Pharmaceutical formulations and methods of medical treatment
JP2004537544A (ja) *	2001-07-13	2004-12-16	パラテックファーマシューティカルズインコーポレイテッド	標的治療活性を有するテトラサイクリン化合物
AU2003265241A1 (en) *	2002-05-23	2003-12-12	Activbiotics, Inc.	Methods of treating bacterial infections and diseases associated therewith

2004
- 2004-09-03 US US10/933,455 patent/US20050148553A1/en not_active Abandoned
- 2004-09-07 WO PCT/US2004/028980 patent/WO2005023263A1/en not_active Ceased
- 2004-09-07 JP JP2006525504A patent/JP2007504249A/ja not_active Withdrawn
- 2004-09-07 KR KR1020067004552A patent/KR20060072135A/ko not_active Abandoned
- 2004-09-07 RU RU2006110936/14A patent/RU2329047C2/ru not_active IP Right Cessation
- 2004-09-07 CN CNA2004800327554A patent/CN1889957A/zh active Pending
- 2004-09-07 ES ES04783278T patent/ES2311860T3/es not_active Expired - Lifetime
- 2004-09-07 SI SI200430890T patent/SI1663233T1/sl unknown
- 2004-09-07 PT PT04783278T patent/PT1663233E/pt unknown
- 2004-09-07 UA UAA200603707A patent/UA83250C2/ru unknown
- 2004-09-07 CA CA002537281A patent/CA2537281A1/en not_active Abandoned
- 2004-09-07 EP EP04783278A patent/EP1663233B1/en not_active Expired - Lifetime
- 2004-09-07 MX MXPA06002414A patent/MXPA06002414A/es active IP Right Grant
- 2004-09-07 PL PL04783278T patent/PL1663233T3/pl unknown
- 2004-09-07 AU AU2004270231A patent/AU2004270231A1/en not_active Withdrawn
- 2004-09-07 DK DK04783278T patent/DK1663233T3/da active
- 2004-09-07 DE DE602004015307T patent/DE602004015307D1/de not_active Expired - Lifetime
- 2004-09-07 BR BRPI0413770-1A patent/BRPI0413770A/pt not_active IP Right Cessation
- 2004-09-07 AT AT04783278T patent/ATE401888T1/de not_active IP Right Cessation
2006
- 2006-02-22 IL IL173878A patent/IL173878A0/en unknown
- 2006-03-31 NO NO20061468A patent/NO20061468L/no not_active Application Discontinuation
- 2006-04-04 CO CO06032753A patent/CO5690590A2/es unknown
- 2006-04-04 EC EC2006006482A patent/ECSP066482A/es unknown

Also Published As

Publication number	Publication date
PL1663233T3 (pl)	2009-05-29
EP1663233B1 (en)	2008-07-23
RU2006110936A (ru)	2007-10-10
BRPI0413770A (pt)	2006-10-31
ATE401888T1 (de)	2008-08-15
DE602004015307D1 (de)	2008-09-04
RU2329047C2 (ru)	2008-07-20
CO5690590A2 (es)	2006-10-31
HK1091754A1 (en)	2007-01-26
EP1663233A1 (en)	2006-06-07
DK1663233T3 (da)	2008-11-10
KR20060072135A (ko)	2006-06-27
SI1663233T1 (sl)	2008-12-31
AU2004270231A1 (en)	2005-03-17
US20050148553A1 (en)	2005-07-07
ECSP066482A (es)	2006-11-24
UA83250C2 (ru)	2008-06-25
CA2537281A1 (en)	2005-03-17
WO2005023263A1 (en)	2005-03-17
IL173878A0 (en)	2006-07-05
PT1663233E (pt)	2008-10-15
MXPA06002414A (es)	2006-08-31
JP2007504249A (ja)	2007-03-01
CN1889957A (zh)	2007-01-03
ES2311860T3 (es)	2009-02-16

Legal Events

Date	Code	Title	Description
2010-04-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
CY1113264T1 (el)	2016-04-13	Συνδυασμοι στροντιου για την προφυλαξη/θεραπεια των παθησεων των χονδρων ή/και των οστων
AP2003002906A0 (en)	2003-12-31	Crystal forms of azithromycin
MXPA04001876A (es)	2004-06-15	Uso de fucanos en el tratamiento de adhesiones, artritis y psoriasis.
AU2002236765A1 (en)	2002-07-30	Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
NZ552047A (en)	2009-11-27	Method of treatment of endobronchial infections
PT1565201T (pt)	2019-02-05	Métodos de administração de dalbavancina para o tratamento de infeções bacterianas
DK1663233T3 (da)	2008-11-10	Anvendelse af tigecyclin, alene eller i kombination med rifampin til behandling af osteomyelitis og/eller septisk arthritis
ATE477758T1 (de)	2010-09-15	Einweg-vorrichtung zur behandlung von infektionen der menschlichen extremitäten
PL352922A1 (en)	2002-09-23	Method of obtaining antibiotic composites and application of them
MD2550C2 (ro)	2005-04-30	Preparat antibiotic cu eliberare lenta a ingredientului activ şi utilizare a acestuia
ECSP045499A (es)	2005-03-10	Macrociclos de amida antibacterianos
BR0309757A (pt)	2005-03-08	6-alquilideno-penemas bicìclicos como inibidores de beta-lactamases
UY28542A1 (es)	2005-04-29	Amidas macrocíclicas antibacterianas
NO20043445L (no)	2004-08-18	Kombinasjonsterapi for behandling av bakterielle infeksjoner
ECSP045405A (es)	2005-01-03	Penems 6-alquiliden heterotriciclil como inhibidores de la beta lactamasa
TW200518741A (en)	2005-06-16	Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis
DK1401448T3 (da)	2010-12-13	Antibakterielle behandling af osteoarthrit
DE60207884D1 (de)	2006-01-12	Monobactam-antibakterielle verbindungen und anwendungsverfahren
NO20042711L (no)	2004-06-30	Fremgangsmate for a behandle bakterielle infeksjoner ved anvendelse av gemifloksasin eller et salt derav et betalaktamantibiotikum
WO2001068675A3 (en)	2001-12-13	Treatment of rosacea
AU2001276323A1 (en)	2002-02-13	Use of n-oleoylethanolamine for treating psoriasis
MY140242A (en)	2009-12-31	BICYCLIC 6-ALKYLIDENE-PENEMS AS ß-LACTAMASES INHIBITORS